ECG Telemetry Devices Market Is Forecasted To Reach A Valuation Of US$ 2.65 billion in 2023

The global ECG telemetry devices market is valued at US$ 2.65 billion in 2023 and is predicted to reach US$ 5.72 billion by 2033, as per a new industry analysis by Fact.MR, a market research and competitive intelligence provider.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.factmr.com/connectus/sample?flag=S&rep_id=8198?PS

A type of gadget called an ECG telemetry device is used to track and record the electrical activities of the heart. It works by detecting the electrical impulses that are produced when cardiac tissue polarises and depolarizes and translating them into waveforms. This method is typically used to identify cardiac irregularities and to examine how a medicine or heart-controlling device is working. The ECG telemetry device can identify complicated dysrhythmias and myocardial ischemia.

The market for electrocardiography (ECG) telemetry devices is boosting due to the increasing demand for home care monitoring devices, respective governments' intervention to provide quality medical devices at an affordable price, growing demand for miniature and telemetry devices, and the rapidly developing global healthcare industry.

𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬 𝐟𝐫𝐨𝐦 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐮𝐝𝐲

• Global demand for ECG telemetry devices is expected to increase at a CAGR of 8% from 2023 to 2033.
• Sales of resting ECG devices are expected to rise at a CAGR of 9% during the forecast period.
• Demand for stress ECG devices is predicted to expand at a CAGR of 7% during the next 10 years.
• China's market for ECG telemetry devices is predicted to expand at a CAGR of 12% during the projected period.

𝐖𝐢𝐧𝐧𝐢𝐧𝐠 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐲

Key manufacturers of ECG telemetry devices are developing advanced portable and wireless ECG devices, and for that, they are highly investing in R&D activities. Such developments by the leading companies are expected to boost their revenue shares and market position.

CardioComm Solutions, Inc. received FDA authorization in February 2019 to use the GEM mobile ECG software as well as the HeartCheck CardiBeat handle head ECG device, which is used to monitor the heartbeat.
The first 12-lead, full-service at-home ECG system for use in decentralised clinical trials was made available by Philips in January 2022.
Competitive Landscape

Key players in the ECG telemetry devices market are Aerotel Medical Systems (1998) Ltd., Cardiac Science Corporation, GE Healthcare, Medtronic, Inc., Nihon Kohden Corporation, Philips Healthcare, Schaeffler AG (Schaeffler Group), Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthineers, and Welch Allyn, Inc.

More small- and mid-sized businesses are anticipated to enter the market in the coming years as a result of the growing emphasis on advanced product creation and the expanding use of technologies in healthcare.

The most portable and slimline personal ECG device "KardiaMobile Card" in the United States was introduced by AliveCor in February 2022. It is the only personal ECG that is portable enough to fit in a wallet and provides real-time heart health information whenever and wherever you need it.

𝐊𝐞𝐲 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐏𝐫𝐨𝐟𝐢𝐥𝐞𝐝

• Aerotel Medical Systems (1998) Ltd.
• Cardiac Science Corporation
• GE Healthcare; Medtronic, Inc.
• Nihon Kohden Corporation
• Philips Healthcare
• Schaeffler AG (Schaeffler Group)
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Siemens Healthineers
• Welch Allyn, Inc.

𝐆𝐞𝐭 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=8198?PS

𝐊𝐞𝐲 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐨𝐟 𝐄𝐂𝐆 𝐓𝐞𝐥𝐞𝐦𝐞𝐭𝐫𝐲 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

By Product :

Resting ECG Devices
Stress ECG Devices
Holter Monitors
Event Monitoring Systems
ECG Management Systems

By Application :

Arrhythmias
Myocardial Ischemia and Infarction
Pacemaker Monitoring
End User :
Home Healthcare
Hospitals
Clinics

By Region :

North America
Latin America
Europe
East Asia
South Asia & Oceania
MEA

Furthermore, the demand for ECG telemetry devices will increase quickly during the forecast period due to the rapid technological developments in the modernization of healthcare practices and the rising research and development efforts in the medical sector.

North America and Europe are dominating marketplaces for ECG telemetry devices due to the presence of key market players. Asia Pacific is considered to be an emerging market for ECG telemetry devices due to rapid developments in healthcare facilities across the region.

𝐌𝐨𝐫𝐞 𝐕𝐚𝐥𝐮𝐚𝐛𝐥𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐨𝐧 𝐎𝐟𝐟𝐞𝐫

Fact.MR, in its new offering, presents an unbiased analysis of the global ECG telemetry devices market, presenting historical demand data (2018-2022) and forecast statistics for the period of 2023-2033.

The study divulges essential insights on the market on the basis of product (resting ECG devices, stress ECG devices, Holter monitors, event monitoring systems, ECG management systems), application (arrhythmias, myocardial ischemia & infarction, pacemaker monitoring), and end user (home healthcare, hospitals, clinics), across five major regions of the world (North America, Europe, Asia Pacific, Latin America, and MEA).

Contact:

Us Sales Office :
11140 Rockville Pike
Suite 400
Rockville, Md 20852
United States
Tel: +1 (628) 251-1583

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories.

This release was published on openPR.